Ugwu, Chinedu
Olumade, Testimony
Nwakpakpa, Ebenezer
Onyia, Venatius
Odeh, Elizabeth
Duruiheoma, Rosemary Ogonna
Ojide, Chiedozie K.
Eke, Matthew Afam
Nwafor, Ifeanyi Emmanuel
Chika-Igwenyi, Nneka
Abu, Augustine M.
Azuogu, Benedict
Ajayi, Nnennaya
Ogah, Emeka
Ayodeji, Oluwafemi
Abejegah, Chukwuyem
Adedosu, Nelson
Oyejide, Nicholas
Abah, Sylvester
Omidele, Abiola
Ingbian, Winifred
Osoba, Emmanuel
Eromon, Philomena
Oluniyi, Paul
Ogunsanya, Olusola
Happi, Anise
Otuh, Patricia
Nadesalingam, Angalee
Carnell, George
Krause, Nina
Aguinam, Ernest
Kinsley, Rebecca
Storisteanu, Daniel Matthew L.
Tonks, Paul
Nelson, Diana
McAlister, Carley
Boisen, Matthew
Garry, Robert
Wright, Edward
Temperton, Nigel
Frost, Simon
Heeney, Jonathan Luke
Happi, Christian
Funding for this research was provided by:
Biotechnology and Biological Sciences Research Council (BB/R020116/1)
Department for International Development (216619/Z/19/Z)
National Institute of Allergy and Infectious Diseases
National Institutes of Health (U01HG007480)
World Bank Group (ACE-IMPACT)
Rockefeller Foundation (Grant #2021 HTH)
Africa Centre for Disease Control (INV018978)
Science for Africa Foundation
Article History
Received: 17 October 2022
Accepted: 8 December 2022
First Online: 25 December 2022
Competing interests
: The authors declare no competing interests.